Nicole Flanagan

Nicole Flanagan is a seasoned professional in the field of genomics, currently serving as Senior Manager at CRISPR Therapeutics since August 2018, where previous roles included Manager I and Senior Research Associate. Prior experience at Dana-Farber Cancer Institute involved supporting next-generation sequencing projects as a Senior Research Technician. Earlier roles included a Molecular and Protein Sciences internship at Alexion Pharmaceuticals, where Nicole developed a transient transfection system, and undergraduate research positions at Boston College and UConn Health, focusing on cancer cell viability and glycosylation studies. Nicole earned a Bachelor of Science in Biochemistry from Boston College in 2013.